Composição do ETF BIB (NASDAQ) - página 11 | MetaTrader

Abrir gráfico completo

Visão geral Todos os ativos Mapa de calor

Principais ativos Valor de mercado Quantidade de ações Participação, %

FULC Fulcrum Therapeutics, Inc. 17.05 K 2 464.00 0.0232%

UPB Upstream Bio, Inc. 16.69 K 1 997.00 0.0227%

KMDA Kamada Ltd. 16.67 K 2 134.00 0.0226%

PACB Pacific Biosciences of California, Inc. 16.63 K 11.16 K 0.0226%

First Tracks Biotherapeutics, Inc. 16.33 K 1 023.00 0.0222%

NGNE Neurogene, Inc. 16.18 K 571.00 0.0220%

CCCC C4 Therapeutics, Inc. 15.77 K 3 609.00 0.0214%

EOLS Evolus, Inc. 15.72 K 2 397.00 0.0213%

Lakefront Biotherapeutics NV 15.54 K 548.00 0.0211%

CTNM Contineum Therapeutics, Inc. 15.16 K 1 124.00 0.0206%

OABI OmniAb, Inc. 14.37 K 5 322.00 0.0195%

ALT Altimmune, Inc. 14.12 K 4 631.00 0.0192%

ENTA Enanta Pharmaceuticals, Inc. 14.11 K 1 072.00 0.0192%

VNDA Vanda Pharmaceuticals, Inc. 14.10 K 2 186.00 0.0191%

LRMR Larimar Therapeutics, Inc. 13.97 K 4 014.00 0.0190%

AUTL Autolus Therapeutics plc 13.86 K 7 414.00 0.0188%

LXEO Lexeo Therapeutics, Inc. 13.86 K 2 697.00 0.0188%

IMRX Immuneering Corp. 13.77 K 2 387.00 0.0187%

LYEL Lyell Immunopharma, Inc. 13.64 K 787.00 0.0185%

AVIR Atea Pharmaceuticals, Inc. 13.49 K 2 889.00 0.0183%

1
...
6
7
8
9
10
11
12
13